Seoul, South Korea

Jae Kwang Chun

This inventor holds 2 USPTO granted patents. Top assignee: Yungjin Pharmaceutical Co., Ltd.. Active years: 1998-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jae Kwang Chun. Retrieved from https://idiyas.com/inventor/jae-kwang-chun

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.2

ph-index = 2

Forward Citations = 13(Granted Patents)


Location History:

  • Kyunggi-do, KR (1998)
  • Seoul, KR (2000)

Company Filing History:


Years Active: 1998-2000

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jae Kwang Chun: Innovator in Pharmaceutical Development

Introduction

Jae Kwang Chun is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds for medical applications. With a total of 2 patents, Chun's work is recognized for its potential impact on treating various skin diseases.

Latest Patents

Chun's latest patents include "Heterocycle-fused thiazole derivatives" and "Pharmaceutical composition for skin diseases." These inventions showcase his expertise in creating effective solutions for complex health issues, particularly in dermatology.

Career Highlights

Chun is currently employed at Yungjin Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work at this esteemed company has positioned him as a key player in the pharmaceutical industry.

Collaborations

Chun collaborates with talented colleagues, including Kae Jong Chung and Man Sik Chang. These partnerships enhance the innovative capacity of their projects and contribute to the overall success of their research initiatives.

Conclusion

Jae Kwang Chun's contributions to pharmaceutical innovation are noteworthy, and his patents reflect his commitment to improving healthcare solutions. His ongoing work at Yungjin Pharmaceutical Co., Ltd. promises to yield further advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…